The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 33.05%.However, over the last six months, we can see a weaker performance of 34.33%. Over the last 30 days, the price of TEVA has fallen by 6.44%. And in the last five days, it has surged by 3.43%.
Teva- Pharmaceutical Industries Ltd. ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $13.93 on 03/22/24 and the lowest value was $7.09 on 05/31/23.
52-week price history of TEVA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -0.29% away from its 52-week high, while its distance from the 52-week low is 96.05%. The stock’s price range during this period has varied between$7.09 and $13.93. The Teva- Pharmaceutical Industries Ltd. ADR’s shares, which operate in the Healthcare, saw a trading volume of around 9.19 million for the day, a figure considerably lower than their average daily volume of 10.71 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 33.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.57B and boasts a workforce of 37226 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.25, with a change in price of +5.77. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 9,799,038 in trading volume during the last 100 days, posting a change of +71.06%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.70. Similarly, the long-term debt-to-equity ratio is also 2.46.
TEVA Stock Stochastic Average
Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the past 50 days is presently 97.45%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 91.71%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 81.33% and 69.79%, respectively.
